Evidence map›Paper›PMID 36000897›Full record

ArticleMicrobiology spectrum2022

Emergence and Spread of the SARS-CoV-2 Variant of Concern Delta across Different Brazilian Regions.

Ighor Arantes, Felipe Gomes Naveca, Tiago Gräf, COVID-19 Fiocruz Genomic Surveillance Network,, Fábio Miyajima, Helisson Faoro, Gabriel Luz Wallau, Edson Delatorre, Luciana Reis Appolinario, Elisa Cavalcante Pereira and 6 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ighor ArantesLaboratório de Vírus Respiratórios e Sarampo, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.ORCID 0000-0002-4131-5338
Felipe Gomes NavecaLaboratório de Ecologia de Doenças Transmissíveis da Amazônia (EDTA), Instituto Leônidas e Maria Deane, Fundação Oswaldo Cruz (FIOCRUZ), Manaus, Amazonas, Brazil.
Tiago GräfInstituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Bahia, Brazil.
COVID-19 Fiocruz Genomic Surveillance Network,
Fábio MiyajimaAnalytical Competence Molecular Epidemiology Laboratory (ACME), Fundação Oswaldo Cruz (FIOCRUZ), Fortaleza, Ceará, Brazil.
Helisson FaoroInstituto Carlos Chagas (ICC), Fundação Oswaldo Cruz (FIOCRUZ), Curitiba, Paraná, Brazil.
Gabriel Luz WallauInstituto Aggeu Magalhães, Fundação Oswaldo Cruz (FIOCRUZ), Recife, Pernambuco, Brazil.
Edson DelatorreDepartamento de Biologia, Universidade Federal do Espirito Santo (UFES), Alegre, Espírito Santo, Brazil.
Luciana Reis AppolinarioLaboratório de Vírus Respiratórios e Sarampo, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.
Elisa Cavalcante PereiraLaboratório de Vírus Respiratórios e Sarampo, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.ORCID 0000-0003-4866-3682
Tainá Moreira Martins VenasLaboratório de Vírus Respiratórios e Sarampo, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.
Alice Sampaio RochaLaboratório de Vírus Respiratórios e Sarampo, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.
Renata Serrano LopesLaboratório de Vírus Respiratórios e Sarampo, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.ORCID 0000-0002-6263-7221
Marilda Mendonça SiqueiraLaboratório de Vírus Respiratórios e Sarampo, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.
Gonzalo BelloLaboratório de AIDS e Imunologia Molecular, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.ORCID 0000-0002-2724-2793
Paola Cristina ResendeLaboratório de Vírus Respiratórios e Sarampo, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brazil.ORCID 0000-0002-2884-3662

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SARS-CoV-2 variant of concern (VOC) Delta was first detected in India in October 2020. The first imported cases of the Delta variant in Brazil were identified in April 2021 in the southern region, followed by more cases in different regions during the following months. By early September 2021, Delta was already the dominant variant in the southeastern (87%), southern (73%), and northeastern (52%) Brazilian regions. This study aimed to understand the spatiotemporal dissemination dynamics of Delta in Brazil. To this end, we employed a combination of maximum likelihood (ML) and Bayesian methods to reconstruct the evolutionary relationship of 2,264 VOC Delta complete genomes (482 from this study) recovered across 21 of the 27 Brazilian federal units. Our phylogeographic analyses identified three major transmission clusters of Delta in Brazil. The clade BR-I (

Indexed as

COVID-19SARS-CoV-2Bayes TheoremBrazilHumansPandemicsB.1.617.2BrazilCOVID-19DeltaSARS-CoV-2variant of concern

Identifiers

PMID36000897
PMCPMC9604183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.